General Information
Revision date
2021-09-08
Product name
Emavusertib
CAS No.
1801344-14-8
1.2.1 Relevant identified uses
For laboratory research purposes Not for drug or household use
Manufacturer Name
BioVision, Inc
Emergency telephone
858-373-8066
Icons in SDS
Company Information
company name
BioVision, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
sds@biovision.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
NFPA Rating Product Name/Chemical Name Description Volume Safety Information Emavusertib Solid B3378-5: 5 mg See below B3378-25: 25 mg Emavusertib: Emergency Overview:
OSHA HCS Classification
Skin corrosion/irritation (Category 2)H315 Sensitisation, skin (Category 1, 1A, 1B)H317 Serious eye damage/eye irritation (Category 2A)H319 Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3)H335
Signal word
Warning
Hazard statements
H315 Causes skin irritation H317 May cause an allergic skin reaction H319 Causes serious eye irritation H335 May cause respiratory irritation.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray P302+P352 IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Health hazards
Flammability: Fire: Reactivity Hazard:
